Metadata Search
Alzheimer's Disease Neuroimaging Initiative
Page 1 of 245 results
Sort by: relevance publication year Download as CSV

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study

Journal Article published 2011 in International Journal of Alzheimer's Disease volume 2011 on pages 1 to 10

Research funded by Alzheimer's Disease Neuroimaging Initiative (U01 AG024904)

Authors: Shanker Swaminathan, Sungeun Kim, Li Shen, Shannon L. Risacher, Tatiana Foroud, Nathan Pankratz, Steven G. Potkin, Matthew J. Huentelman, David W. Craig, Michael W. Weiner, Andrew J. Saykin, The Alzheimer's Disease Neuroimaging Initiative (ADNI)

Modeling and predicting AD progression by regression analysis of sequential clinical data

Journal Article published Jun 2016 in Neurocomputing volume 195 on pages 50 to 55

Research funded by Neurotrack Technologies | National Institute of Biomedical Imaging and Bioengineering | Novartis Pharmaceuticals Corporation | Canadian Institutes of Health Research | Pfizer | AbbVie | Bristol-Myers Squibb | CereSpir, Inc. | F. Hoffmann-La Roche | King Abdullah University of Science and Technology | National Institute on Aging | Lundbeckfonden | Lumosity | Elan Pharmaceuticals, Inc. | IXICO Ltd. | Piramal Imaging | Takeda Pharmaceutical Company | Transition Therapeutics | Servier | Alzheimer's Disease Neuroimaging Initiative (U01 AG024904, W81XWH-12-2-0012) | Genentech | Johnson and Johnson | Northern California Institute for Research and Education | Meso Scale Diagnostics | Janssen Research and Development | GE Healthcare | Eli Lilly and Company | Biogen | Merck | Fujirebio Europe | Araclon Biotech | Alzheimer's Drug Discovery Foundation | Alzheimer's Association | NeuroRx Research | EuroImmun | BioClinica | Eisai Inc.

Authors: Qing Xie, Su Wang, Jia Zhu, Xiangliang Zhang

Predicting progression from mild cognitive impairment to Alzheimer's disease using longitudinal callosal atrophy

Journal Article published 2016 in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring volume 2 on pages 68 to 74

Research funded by Neurotrack Technologies | National Institute of Biomedical Imaging and Bioengineering | Novartis Pharmaceuticals Corporation | Canadian Institutes of Health Research | Pfizer | Bristol-Myers Squibb | Eisai Korea | F. Hoffmann-La Roche | National Institute on Aging | U.S. Department of Defense (W81XWH-12-2-0012) | Janssen Alzheimer Immunotherapy Research & Development, LLC. | Elan Pharmaceuticals, Inc. | IXICO Ltd. | National Institutes of Health (U01 AG024904) | Piramal Imaging | Takeda Pharmaceutical Company | Servier | Alzheimer's Disease Neuroimaging Initiative | Genentech | Biogen Idec | Meso Scale Diagnostics | GE Healthcare | Eli Lilly and Company | Johnson & Johnson Pharmaceutical Research & Development LLC. | Merck | Fujirebio Europe | Araclon Biotech | Alzheimer's Drug Discovery Foundation | Alzheimer's Association | NeuroRx Research | EuroImmun | BioClinica | Medpace | Synarc

Authors: Sang Han Lee, Alvin H. Bachman, Donghyeon Yu, Johan Lim, Babak A. Ardekani

Dissociation of Down syndrome and Alzheimer's disease effects with imaging

Journal Article published Jun 2016 in Alzheimer's & Dementia: Translational Research & Clinical Interventions volume 2 issue 2 on pages 69 to 81

Research funded by Neurotrack Technologies | National Institute of Biomedical Imaging and Bioengineering | Novartis Pharmaceuticals Corporation | Canadian Institutes of Health Research | Pfizer | AbbVie | Bristol-Myers Squibb | CereSpir, Inc. | Eisai | F. Hoffmann-La Roche | National Institute on Aging | Small Business Innovation Research (IIP-1256638) | U.S. Department of Defense (W81XWH-12-2-0012) | Lumosity | Janssen Alzheimer Immunotherapy Research & Development, LLC. | Elan Pharmaceuticals, Inc. | IXICO Ltd. | National Institutes of Health (U01 AG024904) | Piramal Imaging | Lundbeck | Takeda Pharmaceutical Company | Servier | Alzheimer's Disease Neuroimaging Initiative | Genentech | Meso Scale Diagnostics | GE Healthcare | Eli Lilly and Company | Biogen | Transition Therapeutics. | Johnson & Johnson Pharmaceutical Research & Development LLC. | Merck | Fujirebio Europe | Araclon Biotech | Alzheimer's Drug Discovery Foundation | Alzheimer's Association | NeuroRx Research | EuroImmun | National Science Foundation | BioClinica

Authors: Dawn C. Matthews, Ana S. Lukic, Randolph D. Andrews, Boris Marendic, James Brewer, Robert A. Rissman, Lisa Mosconi, Stephen C. Strother, Miles N. Wernick, William C. Mobley, Seth Ness, Mark E. Schmidt, Michael S. Rafii

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment

Journal Article published Dec 2017 in Alzheimer's Research & Therapy volume 9 issue 1

Research funded by Alzheimer's Disease Neuroimaging Initiative

Authors: Jung-Min Pyun, the Alzheimer’s Disease Neuroimaging Initiative, Young Ho Park, Hang-Rai Kim, Jeewon Suh, Min Ju Kang, Beom Joon Kim, Young Chul Youn, Jae-Won Jang, SangYun Kim

Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity

Journal Article published 11 May 2018 in BMC Medical Genetics volume 19 issue 1

Research funded by Alzheimer's Disease Neuroimaging Initiative | Taishan Scholars Program of Shandong Province (ts201511109, tsqn20161079) | Qingdao Key Health Discipline Development Fund | Qingdao Outstanding Health Professional Development Fund | Qingdao Innovation and Entrepreneurship Leading Talent Program

Authors: Hao Hu, Alzheimer’s Disease Neuroimaging Initiative, Haiyan Li, Jieqiong Li, Jintai Yu, Lan Tan

New longitudinal Visual Rating Scale Identifies Structural Alterations in People with Mild Cognitive Impairment and Those who are Cognitively Normal

Journal Article published Jul 2018 in International Journal of Gerontology

Research funded by Alzheimer's Disease Neuroimaging Initiative (U01 AG024904) | DOD ADNI (W81XWH-12-2-0012)

Authors: Tomoki Kaneko, Takahiro Mitsui, Kikuko Kaneko, Masumi Kadoya

Association of cerebrospinal fluid Neurogranin with Alzheimer’s disease

Journal Article published 17 Apr 2018 in Aging Clinical and Experimental Research

Research funded by Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant U01 AG024904)

Authors: Lijun Wang, for the Alzheimer’s Disease Neuroimaging Initiative

Computational human head models of tDCS: Influence of brain atrophy on current density distribution

Journal Article published Jan 2018 in Brain Stimulation volume 11 issue 1 on pages 104 to 107

Research funded by Neurotrack Technologies | National Institute of Biomedical Imaging and Bioengineering | Novartis Pharmaceuticals Corporation | Canadian Institutes of Health Research | Pfizer | AbbVie | Bristol-Myers Squibb | CereSpir, Inc. | Eisai | F. Hoffmann-La Roche | National Institute on Aging | U.S. Department of Defense (W81XWH-12-2-0012) | Lundbeckfonden | Lumosity | Janssen Alzheimer Immunotherapy Research & Development, LLC. | Elan Pharmaceuticals, Inc. | IXICO Ltd. | National Institutes of Health (U01 AG024904) | Piramal Imaging | Takeda Pharmaceutical Company | Transition Therapeutics | Servier | Alzheimer's Disease Neuroimaging Initiative | Cognitive Sciences and Technologies Council (290) | Genentech | Northern California Institute for Research and Education | Meso Scale Diagnostics | GE Healthcare | Eli Lilly and Company | Biogen | Johnson & Johnson Pharmaceutical Research & Development LLC. | Merck | Fujirebio Europe | Araclon Biotech | Alzheimer's Drug Discovery Foundation | Alzheimer's Association | NeuroRx Research | EuroImmun | BioClinica

Authors: Shirin Mahdavi, Farzad Towhidkhah

Intrinsic frequency specific brain networks for identification of MCI individuals using resting-state fMRI

Journal Article published Jan 2018 in Neuroscience Letters volume 664 on pages 7 to 14

Research funded by Neurotrack Technologies | National Institute of Biomedical Imaging and Bioengineering | Novartis Pharmaceuticals Corporation | Canadian Institutes of Health Research | Pfizer | AbbVie | Bristol-Myers Squibb | CereSpir, Inc. | Eisai | F. Hoffmann-La Roche | National Institute on Aging | U.S. Department of Defense (W81XWH-12-2-0012) | Lundbeckfonden | Lumosity | Elan Pharmaceuticals, Inc. | IXICO Ltd. | National Institutes of Health | Takeda Pharmaceutical Company | Transition Therapeutics | Servier | Alzheimer's Disease Neuroimaging Initiative (U01 AG024904) | Johnson and Johnson | Meso Scale Diagnostics | Janssen Research and Development | GE Healthcare | Eli Lilly and Company | Biogen | National Natural Science Foundation of China (81470816, 81271549, 61431013) | Merck | Fujirebio Europe | Araclon Biotech | Alzheimer's Drug Discovery Foundation | Alzheimer's Association | NeuroRx Research | EuroImmun | BioClinica

Authors: Long Qian, Li Zheng, Yuqing Shang, Yaoyu Zhang, Yi Zhang